Boothbay Fund Management’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-139,466
Closed -$5.97M 2626
2022
Q4
$5.75M Sell
139,466
-27,900
-17% -$1.13M 0.13% 180
2022
Q3
$7.33M Buy
+167,366
New +$8.11M 0.18% 90
2021
Q3
Sell
-5,427
Closed -$368K 2288
2021
Q2
$368K Buy
+5,427
New +$371K 0.01% 1166
2021
Q1
Sell
-7,046
Closed -$397K 1863
2020
Q4
$397K Buy
+7,046
New +$347K 0.01% 844
2017
Q3
Sell
-8,372
Closed -$644K 815
2017
Q2
$644K Buy
8,372
+5,662
+209% +$423K 0.13% 172
2017
Q1
$202K Buy
+2,710
New +$197K 0.04% 603
2016
Q4
Sell
-4,487
Closed -$299K 991
2016
Q3
$299K Buy
+4,487
New +$286K 0.06% 380

Other funds holding NUVA

Boothbay Fund Management's NUVA Position: Q1 2023 in Review

Boothbay Fund Management sold out of NuVasive, Inc. (NUVA) in Q1 2023, closing a stake of 139,466 shares — an estimated $5.97M sold.

Boothbay Fund Management first reported a position in NUVA in Q3 2016 and held it in 7 quarters. The position peaked at $7.33M in Q3 2022. 241 funds tracked by Wall St. Rank hold NUVA as of Q1 2023.

  • Boothbay Fund Management reported no remaining NuVasive, Inc. position as of Q1 2023 after selling out during the quarter.
  • Boothbay Fund Management sold 139,466 NuVasive, Inc. shares in Q1 2023, an estimated $5.97M.
  • Boothbay Fund Management first reported a position in NuVasive, Inc. in Q3 2016 and held it in 7 quarters.
  • Boothbay Fund Management's NuVasive, Inc. position peaked at $7.33M in Q3 2022.
  • 241 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2023.

Based on Boothbay Fund Management's 13F filing for Q1 2023, filed 15 May 2023.